NBI 1076986
Alternative Names: NBI-1076986; NBI-986Latest Information Update: 25 Feb 2024
At a glance
- Originator Neurocrine Biosciences
- Class
- Mechanism of Action Muscarinic M4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Movement disorders
Highest Development Phases
- Phase I Movement disorders